Skip to content

App-technology to Increase Physical Activity Among Patients With Type 2 Diabetes

App-technology to Enhance Self-care for Patients With Diabetes Type 2 - A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03053336
Enrollment
181
Registered
2017-02-15
Start date
2017-02-21
Completion date
2019-06-30
Last updated
2020-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Type 2 Diabetes Mellitus

Brief summary

The aim of this study is to investigate the effect of using new app-based technology to improve self-care, compared to usual care in patients with type 2 diabetes. The hypothesis is that the intervention, i.e. using the new technology, will have a greater positive effect on physical activity levels and outcomes of HbA1c than usual care.

Interventions

Access to the smartphone-app during 12 weeks. A personal step goal is set for each individual in the app.

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have a diagnosis of type 2 diabetes * 18 years of age or older * Ability to communicate in Swedish * Have and be able to use a smartphone

Exclusion criteria

* Not being able to walk

Design outcomes

Primary

MeasureTime frame
Change in physical activity level (counts/min from accelerometers)baseline and month 3, 6 and 12

Secondary

MeasureTime frameDescription
Steps/dayBaseline and month 3, 6 and 12
Total cholesterol (mmol/L)Baseline and month 3, 6 and 12
HDL-cholesterol (mmol/L)Baseline and month 3, 6 and 12
Triglycerides (mmol/L)Baseline and month 3, 6 and 12
Apolipoprotein A1 (g/l)Baseline and month 3, 6 and 12
Apolipoprotein B (g/l)Baseline and month 3, 6 and 12
Body weight (kg)Baseline and month 3, 6 and 12
Body Mass Index (BMI, kg/m2)Baseline and month 3, 6 and 12
Body compositionBaseline and month 3, 6 and 12Including: %Body Fat, Fat free mass (kg), Muscle mass (kg), Total body water (kg, %)
Waist circumference (cm)Baseline and month 3, 6 and 12
Blood pressure (mmHg)Baseline and month 3, 6 and 12
HbA1c (mmol/mol)Baseline and month 3, 6 and 12

Other

MeasureTime frameDescription
Change in tobacco use habits (smoking and Swedish snuff use)Baseline and month 3, 6 and 12
Change in sleeping habits assessed using a 13 item questionnaireBaseline and month 3, 6 and 12
Change in perceived stress levels using the perceived stress scaleBaseline and month 3, 6 and 12
Change in reported self-efficacy for exerciseBaseline and month 3, 6 and 12One's confidence in walking is assessed
Change in reported self-efficacy diabetes is assessed using a 20 item questionnaireBaseline and month 3, 6 and 12
Change in RAND-36Baseline and month 3, 6 and 12
Change in neighborhood Environment assessed by questions on safety and walking environmentBaseline and month 3, 6 and 12
Social support for exercise assessed using a 6 item questionnaireBaseline and month 3, 6 and 12
Change in dietary habits assessed using a food frequency questionnaireBaseline and month 3, 6 and 12
Change in perceived purpose in lifeBaseline and month 3, 6 and 12

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026